P520: Endoscopic evaluation and factors affecting the endoscopic efficacy during granulomonocytapheresis in moderately-to-severely active ulcerative colitis: a multi-centre retrospective study
ECCO '19 Copenhagen
2019
P521: Pre-operative enteral nutrition in adults with Crohn’s disease: effect on gut microbiota and disease outcomes
ECCO '19 Copenhagen
2019
P522: Expression of markers of early atherosclerosis in inflammatory bowel disease: a prospective cohort of a single referral centre
ECCO '19 Copenhagen
2019
P523: Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn’s disease
ECCO '19 Copenhagen
2019
P524: Systematic review of calcineurin inhibitors (CNI) and vedolizumab (VDZ) combination therapy in acute severe ulcerative colitis (ASUC)
ECCO '19 Copenhagen
2019
P525: The benefits of anti-TNF drug and antidrug antibody (ADAb) level monitoring in a DGH
ECCO '19 Copenhagen
2019
P526: Survey of adherence to treatment in inflammatory bowel disease: ENADEII STUDY
ECCO '19 Copenhagen
2019
P527: Body image dissatisfaction is increased in inflammatory bowel disease compared with healthy matched controls but not diseased controls
ECCO '19 Copenhagen
2019
P529: Exposure–response relationship of vedolizumab subcutaneous treatment in patients with ulcerative colitis: VISIBLE 1
ECCO '19 Copenhagen
2019
P531: Efficacy of tofacitinib maintenance therapy for ulcerative colitis in remitting patients vs. patients with clinical response after 8 weeks of induction treatment
ECCO '19 Copenhagen
2019
P532: Safety and efficacy of endoscopic dilation of small bowel Crohn’s disease strictures by balloon-assisted enteroscopy: pooled analysis of individual data from 210 patients
ECCO '19 Copenhagen
2019
P533: Ustekinumab therapeutic drug monitoring in Crohn’s disease patients with loss of response
ECCO '19 Copenhagen
2019
P534: IBD-related malignancies observed in 2015–2018: 4 years’ results from the prospective nationwide Hungarian registry
ECCO '19 Copenhagen
2019
P536: Thiopurine metabolite levels in pregnant IBD patients and infants following intrauterine thiopurine exposure
ECCO '19 Copenhagen
2019
P537: The impact of early disease control with vedolizumab on surgery rates among patients with Crohn’s disease: a post-hoc analysis of the GEMINI trials
ECCO '19 Copenhagen
2019
P538: Vedolizumab is effective in real life paediatric inflammatory bowel disease: report from the prospective, multi-centre VEDOKIDS cohort study
ECCO '19 Copenhagen
2019
P539: Impact of a multi-disciplinary team meeting for managing inflammatory bowel disease patients: professional practice analysis based on 869 cases
ECCO '19 Copenhagen
2019
P540: Therapeutic drug monitoring in ustekinumab: which factors affect trough levels?
ECCO '19 Copenhagen
2019